Bank of New York Mellon’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400K | Buy |
162,052
+6,060
| +4% | +$15K | ﹤0.01% | 3611 |
|
|
2025
Q1 | $310K | Buy |
155,992
+26,478
| +20% | +$52.7K | ﹤0.01% | 3670 |
|
|
2024
Q4 | $378K | Sell |
129,514
-200
| -0.2% | -$584 | ﹤0.01% | 3643 |
|
|
2024
Q3 | $502K | Sell |
129,714
-40,849
| -24% | -$158K | ﹤0.01% | 3505 |
|
|
2024
Q2 | $877K | Buy |
170,563
+64,600
| +61% | +$332K | ﹤0.01% | 3273 |
|
|
2024
Q1 | $742K | Sell |
105,963
-8,283
| -7% | -$58K | ﹤0.01% | 3303 |
|
|
2023
Q4 | $1.01M | Sell |
114,246
-1,143
| -1% | -$10.1K | ﹤0.01% | 3176 |
|
|
2023
Q3 | $1.1M | Buy |
115,389
+12,176
| +12% | +$116K | ﹤0.01% | 3098 |
|
|
2023
Q2 | $1.51M | Buy |
103,213
+73,145
| +243% | +$1.07M | ﹤0.01% | 2983 |
|
|
2023
Q1 | $370K | Buy |
30,068
+1,052
| +4% | +$12.9K | ﹤0.01% | 3647 |
|
|
2022
Q4 | $539K | Buy |
+29,016
| New | +$539K | ﹤0.01% | 3503 |
|